Illumina Body Map 2: averaged replicates
Name | miRBASE accession |
---|---|
hsa-miR-30a-5p
|
MIMAT0000087 |
hsa-miR-30b-5p
|
MIMAT0000420 |
hsa-miR-30c-5p
|
MIMAT0000244 |
hsa-miR-30d-5p
|
MIMAT0000245 |
hsa-miR-30e-5p
|
MIMAT0000692 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr18_+_52495426 | 1.84 |
ENST00000262094.5
|
RAB27B
|
RAB27B, member RAS oncogene family |
chr5_+_110559784 | 1.71 |
ENST00000282356.4
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV |
chr7_-_27224795 | 1.45 |
ENST00000006015.3
|
HOXA11
|
homeobox A11 |
chr14_-_99737565 | 1.32 |
ENST00000357195.3
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein) |
chr14_-_24047965 | 1.27 |
ENST00000397118.3
ENST00000356300.4 |
JPH4
|
junctophilin 4 |
chr6_-_40555176 | 1.26 |
ENST00000338305.6
|
LRFN2
|
leucine rich repeat and fibronectin type III domain containing 2 |
chr1_+_50574585 | 1.24 |
ENST00000371824.1
ENST00000371823.4 |
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
chr9_-_23821273 | 1.13 |
ENST00000380110.4
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2 |
chr7_-_143059845 | 1.09 |
ENST00000443739.2
|
FAM131B
|
family with sequence similarity 131, member B |
chr6_-_30654977 | 1.02 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
chr1_-_200992827 | 1.01 |
ENST00000332129.2
ENST00000422435.2 |
KIF21B
|
kinesin family member 21B |
chr8_+_24772455 | 1.00 |
ENST00000433454.2
|
NEFM
|
neurofilament, medium polypeptide |
chr10_+_95517566 | 0.98 |
ENST00000542308.1
|
LGI1
|
leucine-rich, glioma inactivated 1 |
chr1_+_12123414 | 0.98 |
ENST00000263932.2
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8 |
chr6_+_45389893 | 0.97 |
ENST00000371432.3
|
RUNX2
|
runt-related transcription factor 2 |
chr16_-_30022293 | 0.97 |
ENST00000565273.1
ENST00000567332.2 ENST00000350119.4 |
DOC2A
|
double C2-like domains, alpha |
chr1_-_220101944 | 0.96 |
ENST00000366926.3
ENST00000536992.1 |
SLC30A10
|
solute carrier family 30, member 10 |
chr12_+_94542459 | 0.93 |
ENST00000258526.4
|
PLXNC1
|
plexin C1 |
chr16_+_28303804 | 0.89 |
ENST00000341901.4
|
SBK1
|
SH3 domain binding kinase 1 |
chr19_+_18208603 | 0.88 |
ENST00000262811.6
|
MAST3
|
microtubule associated serine/threonine kinase 3 |
chr2_-_235405679 | 0.87 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr16_+_2039946 | 0.86 |
ENST00000248121.2
ENST00000568896.1 |
SYNGR3
|
synaptogyrin 3 |
chr15_-_34628951 | 0.86 |
ENST00000397707.2
ENST00000560611.1 |
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
chr2_-_175499294 | 0.85 |
ENST00000392547.2
|
WIPF1
|
WAS/WASL interacting protein family, member 1 |
chr5_-_157002775 | 0.82 |
ENST00000257527.4
|
ADAM19
|
ADAM metallopeptidase domain 19 |
chr19_-_4066890 | 0.82 |
ENST00000322357.4
|
ZBTB7A
|
zinc finger and BTB domain containing 7A |
chr7_-_27219632 | 0.82 |
ENST00000470747.4
|
RP1-170O19.20
|
Uncharacterized protein |
chr4_-_42154895 | 0.81 |
ENST00000502486.1
ENST00000504360.1 |
BEND4
|
BEN domain containing 4 |
chr5_-_72744336 | 0.80 |
ENST00000499003.3
|
FOXD1
|
forkhead box D1 |
chr6_+_117198400 | 0.80 |
ENST00000332958.2
|
RFX6
|
regulatory factor X, 6 |
chr19_-_11450249 | 0.80 |
ENST00000222120.3
|
RAB3D
|
RAB3D, member RAS oncogene family |
chr2_-_100721178 | 0.80 |
ENST00000409236.2
|
AFF3
|
AF4/FMR2 family, member 3 |
chr5_-_132948216 | 0.78 |
ENST00000265342.7
|
FSTL4
|
follistatin-like 4 |
chr2_+_176972000 | 0.78 |
ENST00000249504.5
|
HOXD11
|
homeobox D11 |
chr4_+_174089904 | 0.78 |
ENST00000265000.4
|
GALNT7
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) |
chr2_-_182545603 | 0.78 |
ENST00000295108.3
|
NEUROD1
|
neuronal differentiation 1 |
chr19_+_926000 | 0.76 |
ENST00000263620.3
|
ARID3A
|
AT rich interactive domain 3A (BRIGHT-like) |
chr10_-_23003460 | 0.76 |
ENST00000376573.4
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
chr15_-_65579177 | 0.75 |
ENST00000444347.2
ENST00000261888.6 |
PARP16
|
poly (ADP-ribose) polymerase family, member 16 |
chr3_-_150481164 | 0.75 |
ENST00000312960.3
|
SIAH2
|
siah E3 ubiquitin protein ligase 2 |
chr14_-_38064198 | 0.74 |
ENST00000250448.2
|
FOXA1
|
forkhead box A1 |
chr6_-_16761678 | 0.74 |
ENST00000244769.4
ENST00000436367.1 |
ATXN1
|
ataxin 1 |
chr4_+_57138437 | 0.74 |
ENST00000504228.1
ENST00000541073.1 |
KIAA1211
|
KIAA1211 |
chr3_-_18466787 | 0.73 |
ENST00000338745.6
ENST00000450898.1 |
SATB1
|
SATB homeobox 1 |
chr7_+_66093851 | 0.73 |
ENST00000275532.3
|
KCTD7
|
potassium channel tetramerization domain containing 7 |
chr6_+_105404899 | 0.72 |
ENST00000345080.4
|
LIN28B
|
lin-28 homolog B (C. elegans) |
chr16_+_56225248 | 0.71 |
ENST00000262493.6
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
chr22_+_21271714 | 0.71 |
ENST00000354336.3
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like |
chr1_-_151688528 | 0.70 |
ENST00000290585.4
|
CELF3
|
CUGBP, Elav-like family member 3 |
chr2_-_16847084 | 0.69 |
ENST00000406434.1
ENST00000381323.3 |
FAM49A
|
family with sequence similarity 49, member A |
chr2_-_166651191 | 0.67 |
ENST00000392701.3
|
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
chr1_+_244214577 | 0.67 |
ENST00000358704.4
|
ZBTB18
|
zinc finger and BTB domain containing 18 |
chr20_-_30795511 | 0.67 |
ENST00000246229.4
|
PLAGL2
|
pleiomorphic adenoma gene-like 2 |
chr12_-_53625958 | 0.67 |
ENST00000327550.3
ENST00000546717.1 ENST00000425354.2 ENST00000394426.1 |
RARG
|
retinoic acid receptor, gamma |
chr10_+_73079000 | 0.67 |
ENST00000373189.5
|
SLC29A3
|
solute carrier family 29 (equilibrative nucleoside transporter), member 3 |
chr17_-_29151794 | 0.67 |
ENST00000324238.6
|
CRLF3
|
cytokine receptor-like factor 3 |
chr11_+_65554493 | 0.66 |
ENST00000335987.3
|
OVOL1
|
ovo-like zinc finger 1 |
chrX_+_72223352 | 0.66 |
ENST00000373521.2
ENST00000538388.1 |
PABPC1L2B
|
poly(A) binding protein, cytoplasmic 1-like 2B |
chr1_+_205012293 | 0.66 |
ENST00000331830.4
|
CNTN2
|
contactin 2 (axonal) |
chr5_-_147162078 | 0.66 |
ENST00000507386.1
|
JAKMIP2
|
janus kinase and microtubule interacting protein 2 |
chrX_+_103810874 | 0.65 |
ENST00000372582.1
|
IL1RAPL2
|
interleukin 1 receptor accessory protein-like 2 |
chr1_+_155051305 | 0.65 |
ENST00000368408.3
|
EFNA3
|
ephrin-A3 |
chr1_+_197881592 | 0.65 |
ENST00000367391.1
ENST00000367390.3 |
LHX9
|
LIM homeobox 9 |
chr6_-_42419649 | 0.65 |
ENST00000372922.4
ENST00000541110.1 ENST00000372917.4 |
TRERF1
|
transcriptional regulating factor 1 |
chr6_+_146864829 | 0.65 |
ENST00000367495.3
|
RAB32
|
RAB32, member RAS oncogene family |
chr17_+_35294075 | 0.64 |
ENST00000254457.5
|
LHX1
|
LIM homeobox 1 |
chr1_+_90286562 | 0.64 |
ENST00000525774.1
ENST00000337338.5 |
LRRC8D
|
leucine rich repeat containing 8 family, member D |
chr22_-_37823468 | 0.64 |
ENST00000402918.2
|
ELFN2
|
extracellular leucine-rich repeat and fibronectin type III domain containing 2 |
chr2_+_166095898 | 0.64 |
ENST00000424833.1
ENST00000375437.2 ENST00000357398.3 |
SCN2A
|
sodium channel, voltage-gated, type II, alpha subunit |
chr7_-_123673471 | 0.64 |
ENST00000455783.1
|
TMEM229A
|
transmembrane protein 229A |
chr12_-_90049828 | 0.64 |
ENST00000261173.2
ENST00000348959.3 |
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1 |
chr11_+_46354455 | 0.63 |
ENST00000343674.6
|
DGKZ
|
diacylglycerol kinase, zeta |
chr6_+_64281906 | 0.63 |
ENST00000370651.3
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1 |
chr21_+_30671189 | 0.63 |
ENST00000286800.3
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
chr18_+_60190226 | 0.63 |
ENST00000269499.5
|
ZCCHC2
|
zinc finger, CCHC domain containing 2 |
chr14_+_103058948 | 0.63 |
ENST00000262241.6
|
RCOR1
|
REST corepressor 1 |
chr22_+_40573921 | 0.62 |
ENST00000454349.2
ENST00000335727.9 |
TNRC6B
|
trinucleotide repeat containing 6B |
chr1_-_89591749 | 0.62 |
ENST00000370466.3
|
GBP2
|
guanylate binding protein 2, interferon-inducible |
chr1_-_115632035 | 0.61 |
ENST00000433172.1
ENST00000369514.2 ENST00000369516.2 ENST00000369515.2 |
TSPAN2
|
tetraspanin 2 |
chr8_-_124553437 | 0.61 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
chr4_-_102268628 | 0.60 |
ENST00000323055.6
ENST00000512215.1 ENST00000394854.3 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr3_+_32859510 | 0.60 |
ENST00000383763.5
|
TRIM71
|
tripartite motif containing 71, E3 ubiquitin protein ligase |
chr14_-_93582148 | 0.60 |
ENST00000267615.6
ENST00000553452.1 |
ITPK1
|
inositol-tetrakisphosphate 1-kinase |
chr2_+_32288725 | 0.60 |
ENST00000315285.3
|
SPAST
|
spastin |
chr12_+_104458235 | 0.59 |
ENST00000229330.4
|
HCFC2
|
host cell factor C2 |
chr5_-_37839782 | 0.59 |
ENST00000326524.2
ENST00000515058.1 |
GDNF
|
glial cell derived neurotrophic factor |
chr16_+_29823552 | 0.59 |
ENST00000300797.6
|
PRRT2
|
proline-rich transmembrane protein 2 |
chr1_+_221051699 | 0.58 |
ENST00000366903.6
|
HLX
|
H2.0-like homeobox |
chr7_+_87505544 | 0.57 |
ENST00000265728.1
|
DBF4
|
DBF4 homolog (S. cerevisiae) |
chr22_-_17602200 | 0.57 |
ENST00000399875.1
|
CECR6
|
cat eye syndrome chromosome region, candidate 6 |
chr3_+_141205852 | 0.57 |
ENST00000286364.3
ENST00000452898.1 |
RASA2
|
RAS p21 protein activator 2 |
chr7_+_128784712 | 0.57 |
ENST00000289407.4
|
TSPAN33
|
tetraspanin 33 |
chr16_-_84651673 | 0.56 |
ENST00000262428.4
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chr7_+_18535346 | 0.56 |
ENST00000405010.3
ENST00000406451.4 ENST00000428307.2 |
HDAC9
|
histone deacetylase 9 |
chr7_-_27205136 | 0.56 |
ENST00000396345.1
ENST00000343483.6 |
HOXA9
|
homeobox A9 |
chr10_-_94003003 | 0.55 |
ENST00000412050.4
|
CPEB3
|
cytoplasmic polyadenylation element binding protein 3 |
chr17_-_63052929 | 0.55 |
ENST00000439174.2
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13 |
chr1_+_113217043 | 0.54 |
ENST00000413052.2
|
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
chr15_+_52043758 | 0.54 |
ENST00000249700.4
ENST00000539962.2 |
TMOD2
|
tropomodulin 2 (neuronal) |
chr11_-_134281812 | 0.54 |
ENST00000392580.1
ENST00000312527.4 |
B3GAT1
|
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
chr6_+_391739 | 0.53 |
ENST00000380956.4
|
IRF4
|
interferon regulatory factor 4 |
chr6_+_137243373 | 0.52 |
ENST00000331858.4
|
SLC35D3
|
solute carrier family 35, member D3 |
chr10_+_106400859 | 0.52 |
ENST00000369701.3
|
SORCS3
|
sortilin-related VPS10 domain containing receptor 3 |
chr6_+_114178512 | 0.52 |
ENST00000368635.4
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate |
chrX_+_100474711 | 0.51 |
ENST00000402866.1
|
DRP2
|
dystrophin related protein 2 |
chr2_-_25475120 | 0.51 |
ENST00000380746.4
ENST00000402667.1 |
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha |
chr1_-_85156216 | 0.51 |
ENST00000342203.3
ENST00000370612.4 |
SSX2IP
|
synovial sarcoma, X breakpoint 2 interacting protein |
chr12_+_101188547 | 0.51 |
ENST00000546991.1
ENST00000392979.3 |
ANO4
|
anoctamin 4 |
chr12_-_77459306 | 0.51 |
ENST00000547316.1
ENST00000416496.2 ENST00000550669.1 ENST00000322886.7 |
E2F7
|
E2F transcription factor 7 |
chr1_+_147013182 | 0.51 |
ENST00000234739.3
|
BCL9
|
B-cell CLL/lymphoma 9 |
chr7_-_55640176 | 0.50 |
ENST00000285279.5
|
VOPP1
|
vesicular, overexpressed in cancer, prosurvival protein 1 |
chr15_-_52821247 | 0.50 |
ENST00000399231.3
ENST00000399233.2 |
MYO5A
|
myosin VA (heavy chain 12, myoxin) |
chr5_-_56247935 | 0.50 |
ENST00000381199.3
ENST00000381226.3 ENST00000381213.3 |
MIER3
|
mesoderm induction early response 1, family member 3 |
chr12_-_104234966 | 0.50 |
ENST00000392876.3
|
NT5DC3
|
5'-nucleotidase domain containing 3 |
chr5_-_134369973 | 0.48 |
ENST00000265340.7
|
PITX1
|
paired-like homeodomain 1 |
chr10_-_32636106 | 0.48 |
ENST00000263062.8
ENST00000319778.6 |
EPC1
|
enhancer of polycomb homolog 1 (Drosophila) |
chr1_-_108507631 | 0.48 |
ENST00000527011.1
ENST00000370056.4 |
VAV3
|
vav 3 guanine nucleotide exchange factor |
chr20_-_21494654 | 0.48 |
ENST00000377142.4
|
NKX2-2
|
NK2 homeobox 2 |
chr1_+_6484829 | 0.48 |
ENST00000377828.1
|
ESPN
|
espin |
chr9_-_3525968 | 0.47 |
ENST00000382004.3
ENST00000302303.1 ENST00000449190.1 |
RFX3
|
regulatory factor X, 3 (influences HLA class II expression) |
chr18_-_12702769 | 0.47 |
ENST00000262127.2
|
CEP76
|
centrosomal protein 76kDa |
chr1_-_19283163 | 0.47 |
ENST00000455833.2
|
IFFO2
|
intermediate filament family orphan 2 |
chr3_-_98312548 | 0.47 |
ENST00000264193.2
|
CPOX
|
coproporphyrinogen oxidase |
chr3_+_49591881 | 0.47 |
ENST00000296452.4
|
BSN
|
bassoon presynaptic cytomatrix protein |
chr6_+_106546808 | 0.47 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr12_+_57916466 | 0.46 |
ENST00000355673.3
|
MBD6
|
methyl-CpG binding domain protein 6 |
chr14_-_69446034 | 0.46 |
ENST00000193403.6
|
ACTN1
|
actinin, alpha 1 |
chr7_+_21467642 | 0.46 |
ENST00000222584.3
ENST00000432066.2 |
SP4
|
Sp4 transcription factor |
chr6_+_160390102 | 0.46 |
ENST00000356956.1
|
IGF2R
|
insulin-like growth factor 2 receptor |
chr3_-_129407535 | 0.46 |
ENST00000432054.2
|
TMCC1
|
transmembrane and coiled-coil domain family 1 |
chr11_+_94277017 | 0.46 |
ENST00000358752.2
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) |
chr2_-_26205340 | 0.45 |
ENST00000264712.3
|
KIF3C
|
kinesin family member 3C |
chr1_+_107683644 | 0.45 |
ENST00000370067.1
|
NTNG1
|
netrin G1 |
chr8_-_33424636 | 0.45 |
ENST00000256257.1
|
RNF122
|
ring finger protein 122 |
chr2_-_176948641 | 0.45 |
ENST00000308618.4
|
EVX2
|
even-skipped homeobox 2 |
chr17_+_42634844 | 0.45 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
chr12_-_122751002 | 0.45 |
ENST00000267199.4
|
VPS33A
|
vacuolar protein sorting 33 homolog A (S. cerevisiae) |
chr5_-_100238956 | 0.45 |
ENST00000231461.5
|
ST8SIA4
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
chr6_-_90062543 | 0.45 |
ENST00000435041.2
|
UBE2J1
|
ubiquitin-conjugating enzyme E2, J1 |
chr17_-_42200996 | 0.45 |
ENST00000587135.1
ENST00000225983.6 ENST00000393622.2 ENST00000588703.1 |
HDAC5
|
histone deacetylase 5 |
chr5_+_179159813 | 0.45 |
ENST00000292599.3
|
MAML1
|
mastermind-like 1 (Drosophila) |
chr6_-_13711773 | 0.44 |
ENST00000011619.3
|
RANBP9
|
RAN binding protein 9 |
chr12_-_53893399 | 0.44 |
ENST00000267079.2
|
MAP3K12
|
mitogen-activated protein kinase kinase kinase 12 |
chr18_+_54318616 | 0.44 |
ENST00000254442.3
|
WDR7
|
WD repeat domain 7 |
chr1_-_116383738 | 0.44 |
ENST00000320238.3
|
NHLH2
|
nescient helix loop helix 2 |
chr5_+_56111361 | 0.44 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
chr15_+_60296421 | 0.43 |
ENST00000396057.4
|
FOXB1
|
forkhead box B1 |
chr12_-_76953284 | 0.43 |
ENST00000547544.1
ENST00000393249.2 |
OSBPL8
|
oxysterol binding protein-like 8 |
chr2_-_200322723 | 0.43 |
ENST00000417098.1
|
SATB2
|
SATB homeobox 2 |
chr19_-_6110474 | 0.43 |
ENST00000587181.1
ENST00000587321.1 ENST00000586806.1 ENST00000589742.1 ENST00000592546.1 ENST00000303657.5 |
RFX2
|
regulatory factor X, 2 (influences HLA class II expression) |
chr11_-_116968987 | 0.43 |
ENST00000434315.2
ENST00000292055.4 ENST00000375288.1 ENST00000542607.1 ENST00000445177.1 ENST00000375300.1 ENST00000446921.2 |
SIK3
|
SIK family kinase 3 |
chr10_+_64893039 | 0.42 |
ENST00000277746.6
ENST00000435510.2 |
NRBF2
|
nuclear receptor binding factor 2 |
chr1_+_174769006 | 0.42 |
ENST00000489615.1
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr1_-_6240183 | 0.42 |
ENST00000262450.3
ENST00000378021.1 |
CHD5
|
chromodomain helicase DNA binding protein 5 |
chr20_-_60982330 | 0.42 |
ENST00000279101.5
|
CABLES2
|
Cdk5 and Abl enzyme substrate 2 |
chr18_+_55102917 | 0.42 |
ENST00000491143.2
|
ONECUT2
|
one cut homeobox 2 |
chr12_-_85306594 | 0.41 |
ENST00000266682.5
|
SLC6A15
|
solute carrier family 6 (neutral amino acid transporter), member 15 |
chr20_+_58508817 | 0.41 |
ENST00000358293.3
|
FAM217B
|
family with sequence similarity 217, member B |
chr4_+_40058411 | 0.41 |
ENST00000261435.6
ENST00000515550.1 |
N4BP2
|
NEDD4 binding protein 2 |
chr2_-_24149977 | 0.41 |
ENST00000238789.5
|
ATAD2B
|
ATPase family, AAA domain containing 2B |
chr3_-_52312636 | 0.41 |
ENST00000296490.3
|
WDR82
|
WD repeat domain 82 |
chr20_+_54933971 | 0.40 |
ENST00000371384.3
ENST00000437418.1 |
FAM210B
|
family with sequence similarity 210, member B |
chr13_-_50367057 | 0.40 |
ENST00000261667.3
|
KPNA3
|
karyopherin alpha 3 (importin alpha 4) |
chr2_-_68479614 | 0.40 |
ENST00000234310.3
|
PPP3R1
|
protein phosphatase 3, regulatory subunit B, alpha |
chr6_-_20212630 | 0.40 |
ENST00000324607.7
ENST00000541730.1 ENST00000536798.1 |
MBOAT1
|
membrane bound O-acyltransferase domain containing 1 |
chr8_-_116681221 | 0.40 |
ENST00000395715.3
|
TRPS1
|
trichorhinophalangeal syndrome I |
chr3_-_182698381 | 0.40 |
ENST00000292782.4
|
DCUN1D1
|
DCN1, defective in cullin neddylation 1, domain containing 1 |
chr14_-_74253948 | 0.40 |
ENST00000394071.2
|
ELMSAN1
|
ELM2 and Myb/SANT-like domain containing 1 |
chr1_-_197169672 | 0.39 |
ENST00000367405.4
|
ZBTB41
|
zinc finger and BTB domain containing 41 |
chr18_-_67624160 | 0.39 |
ENST00000581982.1
ENST00000280200.4 |
CD226
|
CD226 molecule |
chr10_-_48416849 | 0.39 |
ENST00000249598.1
|
GDF2
|
growth differentiation factor 2 |
chr10_-_60027642 | 0.39 |
ENST00000373935.3
|
IPMK
|
inositol polyphosphate multikinase |
chr1_+_179923873 | 0.39 |
ENST00000367607.3
ENST00000491495.2 |
CEP350
|
centrosomal protein 350kDa |
chr2_-_209119831 | 0.39 |
ENST00000345146.2
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble |
chr6_-_45345597 | 0.39 |
ENST00000371460.1
ENST00000371459.1 |
SUPT3H
|
suppressor of Ty 3 homolog (S. cerevisiae) |
chr2_+_102508955 | 0.39 |
ENST00000414004.2
|
FLJ20373
|
FLJ20373 |
chrX_-_39956656 | 0.38 |
ENST00000397354.3
ENST00000378444.4 |
BCOR
|
BCL6 corepressor |
chr22_+_21771656 | 0.38 |
ENST00000407464.2
|
HIC2
|
hypermethylated in cancer 2 |
chr8_+_107670064 | 0.38 |
ENST00000312046.6
|
OXR1
|
oxidation resistance 1 |
chr1_+_15943995 | 0.38 |
ENST00000480945.1
|
DDI2
|
DNA-damage inducible 1 homolog 2 (S. cerevisiae) |
chr19_+_41816053 | 0.38 |
ENST00000269967.3
|
CCDC97
|
coiled-coil domain containing 97 |
chr16_+_50187556 | 0.38 |
ENST00000561678.1
ENST00000357464.3 |
PAPD5
|
PAP associated domain containing 5 |
chr14_-_58332774 | 0.37 |
ENST00000556826.1
|
SLC35F4
|
solute carrier family 35, member F4 |
chr19_+_18263928 | 0.37 |
ENST00000222254.8
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta) |
chr7_-_27135591 | 0.37 |
ENST00000343060.4
ENST00000355633.5 |
HOXA1
|
homeobox A1 |
chr9_-_115095883 | 0.37 |
ENST00000450374.1
ENST00000374255.2 ENST00000334318.6 ENST00000374257.1 |
PTBP3
|
polypyrimidine tract binding protein 3 |
chr2_-_169104651 | 0.37 |
ENST00000355999.4
|
STK39
|
serine threonine kinase 39 |
chr22_-_50913371 | 0.37 |
ENST00000348911.6
ENST00000380817.3 ENST00000390679.3 |
SBF1
|
SET binding factor 1 |
chr1_+_118148556 | 0.37 |
ENST00000369448.3
|
FAM46C
|
family with sequence similarity 46, member C |
chr3_-_183979251 | 0.36 |
ENST00000296238.3
|
CAMK2N2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr3_+_36421826 | 0.36 |
ENST00000273183.3
|
STAC
|
SH3 and cysteine rich domain |
chr3_+_196295482 | 0.36 |
ENST00000440469.1
ENST00000311630.6 |
FBXO45
|
F-box protein 45 |
chr22_+_50247449 | 0.36 |
ENST00000216268.5
|
ZBED4
|
zinc finger, BED-type containing 4 |
chr7_-_149194843 | 0.36 |
ENST00000458143.2
ENST00000340622.3 |
ZNF746
|
zinc finger protein 746 |
chr1_-_234745234 | 0.35 |
ENST00000366610.3
ENST00000366609.3 |
IRF2BP2
|
interferon regulatory factor 2 binding protein 2 |
chr17_-_74449252 | 0.35 |
ENST00000319380.7
|
UBE2O
|
ubiquitin-conjugating enzyme E2O |
chr17_-_65241281 | 0.35 |
ENST00000358691.5
ENST00000580168.1 |
HELZ
|
helicase with zinc finger |
chr3_+_180630090 | 0.35 |
ENST00000357559.4
ENST00000305586.7 |
FXR1
|
fragile X mental retardation, autosomal homolog 1 |
chr14_+_53196872 | 0.35 |
ENST00000442123.2
ENST00000354586.4 |
STYX
|
serine/threonine/tyrosine interacting protein |
chr9_-_16870704 | 0.35 |
ENST00000380672.4
ENST00000380667.2 ENST00000380666.2 ENST00000486514.1 |
BNC2
|
basonuclin 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.4 | 1.3 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.3 | 1.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 1.0 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.3 | 0.8 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.2 | 0.7 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.2 | 0.7 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.2 | 0.6 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.2 | 0.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.8 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.2 | 0.6 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.2 | 0.5 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.9 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.2 | 0.5 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.2 | 0.5 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.2 | 0.7 | GO:0060168 | regulation of axon diameter(GO:0031133) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.2 | 0.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 0.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 0.5 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.1 | 0.6 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.1 | 0.7 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 1.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.7 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.1 | 0.7 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 0.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.1 | 0.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 0.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 0.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 1.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.6 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 0.5 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.9 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.1 | 0.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 | 0.5 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
0.1 | 1.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.3 | GO:0050904 | diapedesis(GO:0050904) |
0.1 | 0.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 1.2 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.3 | GO:0070666 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.6 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.1 | 1.3 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.3 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.1 | 0.5 | GO:0051643 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) endoplasmic reticulum localization(GO:0051643) |
0.1 | 0.3 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
0.1 | 0.3 | GO:0032848 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.1 | 0.2 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.1 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.5 | GO:0003150 | membranous septum morphogenesis(GO:0003149) muscular septum morphogenesis(GO:0003150) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.3 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.1 | 0.5 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
0.1 | 0.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 1.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.5 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 1.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.4 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.1 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.5 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.7 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
0.1 | 0.2 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.3 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.0 | 0.6 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.0 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.0 | 0.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.0 | 0.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 1.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.0 | GO:0072054 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
0.0 | 0.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.7 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 0.1 | GO:0036292 | DNA rewinding(GO:0036292) |
0.0 | 0.2 | GO:0046619 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
0.0 | 0.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.4 | GO:0021902 | forebrain neuron fate commitment(GO:0021877) commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.2 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.0 | 0.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.2 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.0 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.0 | 0.1 | GO:0097368 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 1.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.1 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.0 | 0.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.4 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.0 | 0.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.0 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.6 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.0 | 0.1 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.0 | 0.0 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.6 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.1 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.0 | 0.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.0 | 0.1 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.0 | 0.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.2 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.1 | GO:0035283 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.0 | 0.5 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.2 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.5 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.7 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.2 | GO:0048511 | rhythmic process(GO:0048511) |
0.0 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) |
0.0 | 0.4 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.2 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.0 | 0.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.0 | 0.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) histone H2A phosphorylation(GO:1990164) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.0 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.0 | 0.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.1 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.0 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.2 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.0 | 0.3 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.4 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.0 | 0.1 | GO:0050668 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
0.0 | 0.2 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.0 | 0.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.2 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 1.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.6 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.2 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.0 | 0.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.2 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.2 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 0.0 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.0 | 0.2 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.0 | 0.1 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.0 | 0.3 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.0 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.0 | 0.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.3 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.2 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.0 | 0.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.0 | 1.0 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.8 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.2 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.4 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.4 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.3 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.4 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 1.1 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.4 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.0 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.3 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 1.0 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.0 | 0.0 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.0 | 0.1 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.0 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.0 | 0.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.1 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.1 | 1.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.6 | GO:0031905 | early endosome lumen(GO:0031905) |
0.1 | 1.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.7 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.3 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.1 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.6 | GO:0042025 | host cell nucleus(GO:0042025) |
0.1 | 0.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.2 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
0.1 | 0.2 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 0.2 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.1 | 0.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 0.2 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 1.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.2 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.0 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.3 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.0 | 1.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.2 | GO:0031213 | RSF complex(GO:0031213) |
0.0 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.1 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.0 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.2 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.0 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 1.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 3.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.9 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.1 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 1.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 2.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.6 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 1.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.5 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.0 | 1.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.7 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 0.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 0.6 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.4 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.1 | 0.7 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 0.4 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 0.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.4 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 3.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 1.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.1 | 1.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 1.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.1 | GO:0052827 | inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.1 | 0.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 1.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.2 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.1 | 0.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.2 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.1 | 0.2 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
0.1 | 0.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 1.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 2.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 1.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.3 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.0 | 1.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 1.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.2 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.0 | 0.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.1 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.0 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
0.0 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.0 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 1.1 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 1.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.2 | GO:0043532 | angiostatin binding(GO:0043532) |
0.0 | 1.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0031692 | alpha-1B adrenergic receptor binding(GO:0031692) |
0.0 | 0.3 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.0 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.1 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.0 | 0.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 2.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 1.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.3 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 2.1 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 1.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.2 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.0 | 0.0 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.0 | 0.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 1.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 1.2 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.0 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 1.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.7 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 4.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 2.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 3.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 1.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.6 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 1.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 1.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 1.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 2.7 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 1.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 1.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 1.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.6 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 1.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |